Page results
-
The service offers a holistic, multidisciplinary approach to the evaluation and treatment of bladder, bowel and sexual dysfunction in individuals with established and suspected neurological disorders.
-
Information about the EGA Hospital Charity at UCLH
-
Mouth cancer is where a tumour develops on the surface of the tongue, lips, gums or jaws.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
The Lysholm Department of Neuroradiology is a multidisciplinary team of healthcare professionals providing leading-edge neuroradiological services, performing around 60,000 examinations and procedures per year.
-
The department provides a unique and highly specialised clinical neuropsychological diagnostic and therapeutic service for in- and outpatients.
-
The department of Neuroanaesthesia and Critical Care has 30 substantive consultant anaesthetists and intensivists as well as approximately 40 resident doctors. It is responsible for the provision of anaesthetic services in the six operating theatres, neuroradiology and the interventional MRI operating suite as well as critical care services at NHNN.
-
This patient information aims to address the questions you may have about surgical management of endometriosis.
-
On 13 January 2020, a consultation which asks for people’s views on the future of planned orthopaedic surgery for adults in north central London was launched.
-
The movement disorders group specialises in the assessment, diagnosis and treatment of people with diseases such as Parkinson’s disease, dystonia, tremor, myoclonus and chorea.
File results
-
FOI/2023/0235 - Hip and knee arthroplasty litigation
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking